Hepatocyte Growth Factor Prevents Pulmonary Ischemia-Reperfusion Injury in Mice

Journal of Heart and Lung Transplantation

Volumn 26, Issue 9, 2007, Pages 935-943

  Makiuchi, Akiko ^a   Yamaura, Kazuhiro ^a   Mizuno, Shinya ^b   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Amano, Jun ^a   Ito, Ken ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL XL; RECOMBINANT SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG INJURY; LUNG TRANSPLANTATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SCORING SYSTEM; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; FEMALE; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUNG; MICE; MICE, INBRED ICR; PULMONARY ALVEOLI; RECOMBINANT PROTEINS; REPERFUSION INJURY;

EID: 34548504128     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.06.010     Document Type: Article

References (51)

1. Fiser S.M., Tribble C.G., Long S.M., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73 (2002) 1041-1047
2. de Perrot M., Liu M., Waddell T.K., and Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490-511
3. Lau C.L., Patterson G.A., and Palmer S.M. Critical care aspects of lung transplantation. J Intensive Care Med 19 (2004) 83-104
4. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
5. Ross S.D., Tribble C.G., Gaughen Jr. J.R., Shockey K.S., Parrino P.E., and Kron I.L. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 67 (1999) 1428-1433
6. Eppinger M.J., Deeb G.M., Bolling S.F., and Ward P.A. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 150 (1997) 1773-1784
7. Haydock D.A., Trulock E.P., Kaiser L.R., et al. Management of dysfunction in the transplanted lung: experience with 7 clinical cases. Ann Thorac Surg 53 (1992) 635-641
8. Bando K., Paradis I.L., Similo S., et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110 (1995) 4-13
9. Snell G.I., Esmore D.S., and Williams T.J. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 109 (1996) 874-878
10. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122 (1984) 1450-1459
11. Nakamura T., Teramoto H., and Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83 (1986) 6489-6493
12. Gohda E., Tsubouchi H., Nakayama H., et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81 (1988) 414-419
13. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
14. Vargas G.A., Hoeflich A., and Jehle P.M. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 57 (2000) 1426-1436
15. Matsumoto K., Mizuno S., and Nakamura T. Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens 9 (2000) 395-402
16. Miller S.B., Martin D.R., Kissane J., and Hammerman M.R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266 (1994) F129-F134
17. Kawaida K., Matsumoto K., Shimazu H., and Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91 (1994) 4357-4361
18. Ueda T., Takeyama Y., Hori Y., et al. Hepatocyte growth factor increases in injured organs and functions as an organotrophic factor in rats with experimental acute pancreatitis. Pancreas 20 (2000) 84-93
19. Oe S., Hiros T., Fujii H., Yasuchika K., et al. Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats. J Hepatol 34 (2001) 832-839
20. Ueda H., Sawa Y., Matsumoto K., et al. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg 67 (1999) 1726-1731
21. Nakamura T., Mizuno S., Matsumoto K., et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106 (2000) 1511-1519
22. Kuenzler K.A., Arthur L.G., and Schwartz M.Z. A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment. J Pediatr Surg 37 (2002) 1696-1699
23. Yamaura K., Ito K., Tsukioka K., et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 110 (2004) 1650-1657
24. Zwirska-Korczala K., Zakliczynski M., Berdowska A., et al. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation. J Heart Lung Transplant 24 (2005) 411-415
25. Ohmichi H., Koshimizu U., Matsumoto K., and Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 125 (1998) 1315-1324
26. Ohmichi H., Matsumoto K., and Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am J Physiol 270 (1996) L1031-L1039
27. Yamada T., Hisanaga M., Nakajima Y., et al. Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat. Am J Respir Crit Care Med 162 (2000) 707-715
28. Sakamaki Y., Matsumoto K., Mizuno S., et al. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol 26 (2002) 525-533
29. Mason R.J., McCormick-Shannon K., et al. Hepatocyte growth factor is a mitogen for alveolar type II cells in rat lavage fluid. Am J Physiol 271 (1996) L46-L53
30. Hayashi S., Morishita R., Nakamura S., et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation 100 (1999) II-301-II-308
31. Miyagawa S., Sawa Y., Taketani S., et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 105 (2002) 2556-2561
32. Yoshida S., Yamaguchi Y., Itami S., et al. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J Invest Dermatol 120 (2003) 335-343
33. Nakanishi K., Uenoyama M., Tomita N., et al. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). Am J Pathol 161 (2002) 1761-1772
34. Ono M., Sawa Y., Matsumoto K., et al. In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung. Circulation 106 (2002) I-264-I-269
35. Nakamura T., Nishizawa T., Hagiya M., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
36. Borghi-Scoazec G., Scoazec J.Y., Durand F., et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transplant Surg 3 (1997) 407-415
37. Burns A.T., Davies D.R., McLaren A.J., et al. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 66 (1998) 872-876
38. Ikeda H., Suzuki Y., Suzuki M., et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 42 (1998) 530-537
39. Freude B., Masters T.N., Robicsek F., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32 (2000) 197-208
40. Fischer S., Maclean A.A., Liu M., et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 162 (2000) 1932-1939
41. Fischer S., Cassivi S.D., Xavier A.M., et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 231 (2000) 424-431
42. Shibuki H., Katai N., Kuroiwa S., et al. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 43 (2002) 528-536
43. Nakatani T., Kim T., Uchida J., et al. Hepatocyte growth factor ameliorates renal hemodynamic disorder after ischemia/reperfusion. Int J Mol Med 10 (2002) 217-219
44. Kuenzler K.A., Pearson P.Y., and Schwartz M.Z. Hepatoctye growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischemia-reperfusion. J Pediatr Surg 37 (2002) 1093-1097
45. Yaekashiwa M., Nakayama S., Ohnuma K., et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 156 (1997) 1937-1944
46. Sakai T., Satoh K., Matsushima K., et al. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am J Respir Cell Mol Biol 16 (1997) 388-397
47. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 277 (1999) F624-F633
48. Wang X., Zhou Y., Kim H.P., et al. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem 279 (2004) 5237-5243
49. Jaffre S., Dehoux M., Paugam C., et al. Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am J Physiol Lung Cell Mol Physiol 282 (2002) L310-L315
50. Gao X., Mae H., Ayabe N., et al. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 62 (2002) 1238-1248
51. Ueki T., Kaneda Y., Tsutsui H., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5 (1999) 226-230